UCapital NewsBusiness Super App · news connected to data, companies, people and deals
IT
VoicesWire
LIVE
BREAKING LIVE

The news moving markets, right now

From international newswires in real time. For every story the News Impact AI agent estimates the market impact and flags the assets to watch, with the story’s impact on each: positive, negative or neutral.

STORIES TODAY
255
via seekingalpha.comPolitics

Hospital association files lawsuit to halt revised 340B drug rebate pilot program

FROM THE WIRE · SEEKINGALPHA.COM

[An overturned pill bottle spills cash and medicinal capsules] Enrique Yocoyani Aguilar Licona/iStock via Getty Images The American Hospital Association has once again filed a lawsuit to halt a new pilot that tests a revised rebate model for the 340B Drug Pricing Program, a…

Read at the source ↗
MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bearishLegal challenge to 340B pilot program could impact pharmaceutical manufacturers' and hospital operators' margins.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
  1. 01American Hospital Association filed lawsuit to halt new 340B pilot program testing revised rebate model.
  2. 02Lawsuit filed in federal court in Maine against HHS Department and Health Resources and Services Administration.
  3. 03Pilot program allows 10 pharmaceutical manufacturers to offer after-the-fact rebates in federal program for uninsured and low-income…
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
AbbVie Inc.ABBVStock276.47 USDMarket closedtoday +1.49%Negative Amgen Inc.AMGNStock414.87 USDMarket closedtoday +1.82%Negative AstraZeneca PLCAZNStock159.20 USDMarket closedtoday +0.26%Negative Bristol-Myers Squibb CompanyBMYStock59.12 USDMarket closedtoday -0.77%Negative Merck & Co., Inc.MRKStock145.60 USDMarket closedtoday +2.26%Negative Pfizer Inc.PFEStock28.28 USDMarket closedtoday +1.65%Negative
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets

ALL BREAKING TODAY

Breaking live stories come from third-party newswires via feed; headline and summary belong to the stated source. Impact analysis: UCapital AI · News Impact.

UCapital News is the news section of UCapital24 S.p.A. All content is for information purposes only and does not constitute financial advice, a recommendation or a solicitation to invest. Even where terms such as “buy”, “sell”, “bullish” or “bearish”, or asset impact signals, appear, they only indicate the possible effect of a news item on the markets and are not an invitation to buy or sell financial instruments. News is analysed with UCapital AI and may also be published via API feeds from third-party providers, to give our users a continuous flow of news. UCapital24 S.p.A. accepts no liability of any kind for decisions made on the basis of this content. Wire releases are published by companies and are not verified by the newsroom.

AI use policy. UCapital AI supports the newsroom with news analysis, summaries, market reactions, translations and the generation of cards and charts. AI-generated or AI-assisted content is labelled in the byline (AI Desk, a named AI profile marked «AI», or joint byline) and is reviewed by editors before publication. News received via API feeds from third-party providers is attributed to the original source. AI can make mistakes: report any inaccuracies to the newsroom. Users’ personal data is not used to train the models.